AU2001282607A1 - Solution preparations stabilized over long time - Google Patents

Solution preparations stabilized over long time

Info

Publication number
AU2001282607A1
AU2001282607A1 AU2001282607A AU2001282607A AU2001282607A1 AU 2001282607 A1 AU2001282607 A1 AU 2001282607A1 AU 2001282607 A AU2001282607 A AU 2001282607A AU 2001282607 A AU2001282607 A AU 2001282607A AU 2001282607 A1 AU2001282607 A1 AU 2001282607A1
Authority
AU
Australia
Prior art keywords
long time
over long
stabilized over
solution preparations
preparations stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001282607A
Other versions
AU2001282607B2 (en
Inventor
Yasushi Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority claimed from PCT/JP2001/007600 external-priority patent/WO2002017957A1/en
Publication of AU2001282607A1 publication Critical patent/AU2001282607A1/en
Application granted granted Critical
Publication of AU2001282607B2 publication Critical patent/AU2001282607B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001282607A 2000-09-01 2001-09-03 Solution preparations stabilized over long time Ceased AU2001282607B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000266095 2000-09-01
JP2000-266095 2000-09-01
PCT/JP2001/007600 WO2002017957A1 (en) 2000-09-01 2001-09-03 Solution preparations stabilized over long time

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2006235962A Division AU2006235962A1 (en) 2000-09-01 2006-11-10 Solution formulations having long-term stability

Publications (2)

Publication Number Publication Date
AU2001282607A1 true AU2001282607A1 (en) 2002-06-06
AU2001282607B2 AU2001282607B2 (en) 2006-08-17

Family

ID=18753248

Family Applications (3)

Application Number Title Priority Date Filing Date
AU8260701A Pending AU8260701A (en) 2000-09-01 2001-09-03 Solution preparations stabilized over long time
AU2001282607A Ceased AU2001282607B2 (en) 2000-09-01 2001-09-03 Solution preparations stabilized over long time
AU2006235962A Abandoned AU2006235962A1 (en) 2000-09-01 2006-11-10 Solution formulations having long-term stability

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU8260701A Pending AU8260701A (en) 2000-09-01 2001-09-03 Solution preparations stabilized over long time

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2006235962A Abandoned AU2006235962A1 (en) 2000-09-01 2006-11-10 Solution formulations having long-term stability

Country Status (9)

Country Link
US (1) US7998929B2 (en)
EP (2) EP1329224A4 (en)
KR (1) KR20030027077A (en)
CN (1) CN1204921C (en)
AU (3) AU8260701A (en)
CA (1) CA2420850A1 (en)
HK (1) HK1057168A1 (en)
NZ (1) NZ524482A (en)
WO (1) WO2002017957A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4147234B2 (en) 2004-09-27 2008-09-10 キヤノン株式会社 Discharge liquid, discharge method, cartridge, and discharge device
WO2004007520A2 (en) * 2002-07-12 2004-01-22 Medarex, Inc. Methods and compositions for preventing oxidative degradation of proteins
US20060058511A1 (en) * 2002-08-27 2006-03-16 Chugai Seiyaku Kabushiki Kaisha Method for stabilizing protein solution preparation
RU2234945C2 (en) * 2002-10-15 2004-08-27 Вардосанидзе Ирина Викторовна Stabilizing agent for aqueous solution and water-containing raw with spontaneously varying oxidative-reductive properties
KR20120104619A (en) * 2003-08-14 2012-09-21 노보 노르디스크 헬스 케어 악티엔게젤샤프트 Liquid, aqueous pharmaceutical composition of factor vii polypeptides
CA2551510C (en) * 2003-12-23 2013-07-30 Pharmacia Corporation Stable growth hormone liquid formulation
BRPI0510295A (en) 2004-05-04 2007-11-06 Novo Nordisk Healthcare Ag preparation of a glycoprotein, and method for producing the same
JP4147235B2 (en) * 2004-09-27 2008-09-10 キヤノン株式会社 Discharge liquid, discharge method, droplet forming method, liquid discharge cartridge, and discharge apparatus
WO2007034509A2 (en) * 2005-09-19 2007-03-29 Zenotech Laboratories Limited Recombinant granulocyte-colony stimulating factor formulation and process
KR100784134B1 (en) 2006-10-09 2007-12-12 주식회사 대웅 Stable liquid compositions for treating mucositis comprising epidermal growth factor
CN101657187B (en) * 2007-04-05 2012-07-18 桑多斯股份公司 Stable aqueous G-CSF formulations
WO2009002521A2 (en) * 2007-06-25 2008-12-31 Amgen Inc. Compositions of specific binding agents to hepatocyte growth factor
KR101087017B1 (en) 2007-07-10 2011-12-09 (주)메디톡스 Stable liquid composition of Botulinum Toxin
MX2010002448A (en) 2007-08-27 2010-10-04 Biogenerix Ag Liquid formulation of g-csf conjugate.
PE20091174A1 (en) * 2007-12-27 2009-08-03 Chugai Pharmaceutical Co Ltd LIQUID FORMULATION WITH HIGH CONCENTRATION OF ANTIBODY CONTENT
MX2012010198A (en) 2010-03-01 2012-10-03 Bayer Healthcare Llc Optimized Monoclonal Antibodies against Tissue Factor Pathway Inhibitor (TFPI).
US9592297B2 (en) 2012-08-31 2017-03-14 Bayer Healthcare Llc Antibody and protein formulations
US8613919B1 (en) 2012-08-31 2013-12-24 Bayer Healthcare, Llc High concentration antibody and protein formulations
WO2016127887A1 (en) 2015-02-11 2016-08-18 杭州鸿运华宁生物医药工程有限公司 Stabilized solution preparation of pharmaceutical glp-1r antibody fusion protein
WO2023066988A1 (en) 2021-10-19 2023-04-27 Sandoz Ag Glass container with low aluminum content and gas overlay to prevent oxidation of sensitive therapeutic agents

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2577744B2 (en) 1986-07-18 1997-02-05 中外製薬株式会社 Stable granulocyte colony-stimulating factor containing preparation
GR871067B (en) 1986-07-18 1987-11-19 Chugai Pharmaceutical Co Ltd Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor
JP2577742B2 (en) 1986-07-18 1997-02-05 中外製薬株式会社 Stable granulocyte colony-stimulating factor containing preparation
JPH02116515A (en) 1988-10-26 1990-05-01 Matsushita Electric Works Ltd Manufacture of inorganic building material
US5166322A (en) 1989-04-21 1992-11-24 Genetics Institute Cysteine added variants of interleukin-3 and chemical modifications thereof
US5272135A (en) * 1991-03-01 1993-12-21 Chiron Ophthalmics, Inc. Method for the stabilization of methionine-containing polypeptides
DE4126984A1 (en) 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh PROCESS FOR THE MANUFACTURE OF HUMAN PROTEIN-CONTAINING, SUITABLE MEDICAMENTS FOR INFUSION OR INJECTION USE
DE4242863A1 (en) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Stable lyophilized pharmaceutical preparations of G-CSF
DE4242919A1 (en) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Process for the preparation of storage-stable aqueous pharmaceutical preparations of G-CSF
US5358708A (en) * 1993-01-29 1994-10-25 Schering Corporation Stabilization of protein formulations
NZ260909A (en) * 1993-07-05 1995-04-27 Takeda Chemical Industries Ltd Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
US5607400A (en) * 1995-05-19 1997-03-04 Becton, Dickinson And Company Pre-fillable syringe and stopper assembly therefor
JP3895109B2 (en) * 1998-03-06 2007-03-22 中外製薬株式会社 Protein-free formulation
JP2000247903A (en) * 1999-03-01 2000-09-12 Chugai Pharmaceut Co Ltd Long-term stabilized pharmaceutical preparation
US6646110B2 (en) * 2000-01-10 2003-11-11 Maxygen Holdings Ltd. G-CSF polypeptides and conjugates

Similar Documents

Publication Publication Date Title
AU2001236005A1 (en) Preparations stabilized over long time
AU2001294192A1 (en) Solid preparations
AU2001277781A1 (en) Stabilized antibody-containing preparations
AU2001232799A1 (en) Protein c derivatives
AU2001276737A1 (en) Protein injection preparations
AU2001282607A1 (en) Solution preparations stabilized over long time
AU2001295657A1 (en) Formulation containing wax-esters
AU2001282617A1 (en) Compositions for external preparations
AU2001274548A1 (en) Syringe
AU8260701A (en) Solution preparations stabilized over long time
AU2001278755A1 (en) Injections
AU5469801A (en) Pro-liposomal encapsulated preparations (iv)
AU3089199A (en) Preparations containing licariin
AU2001242479A1 (en) Proliposomal encapsulated preparations
AU2001240791A1 (en) Sequence
AU3929799A (en) Effervescent preparations
AU2001259450A1 (en) Cytoskeleton-associated proteins
AU2002224053A1 (en) Dry syrup preparations
AU2001288102A1 (en) Solid preparations
AU2001282521A1 (en) OCT preparations
AU2001232335A1 (en) Skin preparations for external use
AU2001272427A1 (en) Solid preparations
AU8252101A (en) Oct preparations
AU2001296389A1 (en) Stable peptide formulations
AU2002239747A1 (en) Cystoskeleton-associated proteins